Antibody Validation Protocol Article Reveals Surprises For Bioscientists

BitesizeBio.com has published its latest article covering antibody validation for scientific researchers. The article is part of BitesizeBio’s Sponsored Education series, and is produced with the assistance of GenScript, a leading life sciences services and products company.

Dundee, United Kingdom – June 23, 2017 /PressCable/ —

BitesizeBio.com has published a new article entitled “Antibody Validation”, which sheds light on the most important aspects of antibody validation for scientific researchers. Bioscientists, and those interested in the topic, can view the full article on the BitesizeBio website

BitesizeBio.com is used by individual scientists and companies to share their wisdom, know-how and solutions, to creating what has been called “The Missing Manual for Bioscientists”. The website is used, loved and depended-upon by hundreds of thousands of visitors each month.

The article includes several interesting pieces of information, one in particular is that there is no established criteria for antibody validation, but agencies often require researchers to validate antibodies in order to receive funding. This should be of particular interest to bioscientists because many antibody validation methods exist and can be used in combination, although established criteria is lacking.

One of the most important piece of information the article communicates is that more than one method should be used to validate any antibody. The best example of this is perhaps found in the following extract:

‘Not all antibodies are valid for every experiment and condition, and they must be validated for the specific application and species. Currently, there is no standard means of “antibody validation,” and this can greatly impact experimental reproducibility and reliability. Journals and granting agencies have taken steps to address this gap.’

This article is part of BitesizeBio’s Sponsored Education series, and is produced with the assistance of GenScript. GenScript provide life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, they are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services.

Dr. Amanda Welch, Editor-in-Chief of BitesizeBio.com, said, “This article addresses an important criteria required by funding agencies: Antibody validation. The various methods and protocols are addressed in this articles, which can help researchers with grant writing and obtaining funding.”

BitesizeBio.com now welcomes comments and questions from readers, in relation to the article, which can be posted on the webpage.

To keep up to date with the latest articles, follow Bitesize Bio on Facebook.

Contact Info:
Name: Dr. Nick Oswald
Email: nick@bitesizebio.com
Organization: Science Squared Ltd.
Address: The Vision Building 20 Greenmarket, Dundee DD1 4QB, United Kingdom

For more information, please visit http://bitesizebio.com

Source: PressCable

Release ID: 210397